Staff Bios and Credentials

Richard J. Braun, MBA, JD, was named Chairman of the Board of Directors and President on October 26, 2000. Mr. Braun was named a director and elected as Chief Executive Officer in July 1996. From 1994 until joining the Company, Mr. Braun acted as a private investor and provided management consulting services to the health care and technology industries. From 1992 until 1994, he served as Chief Operating Officer and as a director of EBP, Inc., a NYSE company engaged in managed care. From 1989 through 1991, Mr. Braun served as Executive Vice President, Chief Operating Officer and as a director of Reich and Tang L.P., a NYSE investment advisory and broker dealer firm.

Angela M. Lacis, CPA (inactive), was appointed Corporate Controller on April 15, 2010, and serves as our Principal Accounting Officer.  Ms. Lacis has over 14 years of finance and accounting experience.  She joined MEDTOX Laboratories in 2000 and has served in various positions relating to finance.  Ms. Lacis has served as the Company's Internal Financial Auditor since March of 2007.  From June 2003 to March 2007, she previously served as Corporate Controller and Principal Accounting Officer for the Company.

B. Mitchell Owens, MBA, was appointed Vice President and Chief Operating Officer of MEDTOX Diagnostics, Inc. on July 17, 2000.  Mr. Owens has over 23 years of experience in the diagnostics industry.  He joined the Company in 1988 and has served in various positions, including Director of Operations and General Manager.  Prior to joining the Company, Mr. Owens was employed by GTE Technical Products Division and Kayser-Roth Corporation in related operations management positions.

Susan E. Puskas, MT (ASCP) SC, was appointed COO, Clinical Laboratory Operations on June 15, 2010, in addition to her position as Vice President, Quality Assurance and Regulatory Affairs which she has held since May 23, 2002.  Ms. Puskas is a board certified Medical Technologist and Specialist in Clinical Chemistry through the American Society of Clinical Pathologists.  Ms. Puskas has been with MEDTOX since 1991.  With over 35 years of clinical laboratory experience (greater than 30 years as a director/manager/ supervisor), she oversees the quality systems and regulatory affairs of the Company as well as the clinical laboratory operations.

James A. Schoonover, MBA, was named Vice President of Sales and Marketing and Chief Marketing Officer on July 17, 2000. Mr. Schoonover joined the Company in August 1997 and has more than 25 years of experience in sales, public relations and sales management for a variety of service companies. Prior to joining MEDTOX Scientific, Inc., Mr. Schoonover was a Division Vice President for the medical services subsidiary of Olsten Corporation.

Charlotte L. Sebastian, MA, SPHR, was appointed Vice President, Human Resources on May 26, 2009.  She joined the Company as Director of Human Resources on July 11, 2005.  Ms. Sebastian has over 30 years of experience as an HR professional, including management positions at Mentor Corporation, Medtronic, and the Wilder Foundation.

Kevin J. Wiersma, was appointed Chief Administrative Officer on June 15, 2010.  He was named Chief Financial Officer on May 22, 2002 and Chief Operating Officer on July 17, 2000.  He was named Vice President on July 20, 1998.  Mr. Wiersma joined MEDTOX Laboratories in 1992 and continued with the company following its acquisition by MEDTOX Scientific, Inc.  Mr. Wiersma has served in various positions relating to finance and operations management within the Company.